Simplex Trading, LLC Anavex Life Sciences Corp. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Simplex Trading, LLC holds 6,756 shares of AVXL stock, worth $58,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,756

Holding current value

$58,371

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$4.11 - $7.04 $27,767 - $47,562	6,756 New	6,756 $38,000
Q4 2023 Feb 02, 2024	BUY	$5.04 - $9.95 $363,565 - $717,753	72,136 New	72,136 $671,000
Q2 2023 Aug 04, 2023	SELL	$7.66 - $9.5 $194,089 - $240,711	-25,338 Reduced 41.4%	35,867 $291,000
Q1 2023 Apr 27, 2023	BUY	$8.32 - $11.75 $509,225 - $719,158	61,205 New	61,205 $524,000
Q1 2022 May 02, 2022	SELL	$9.74 - $17.69 $113,061 - $205,345	-11,608 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$16.88 - $23.31 $189,798 - $262,097	-11,244 Reduced 49.2%	11,608 $201,000
Q3 2021 Oct 28, 2021	BUY	$16.82 - $25.75 $49,484 - $75,756	2,942 Added 14.78%	22,852 $561,000
Q2 2021 Aug 12, 2021	SELL	$10.16 - $28.86 $53,370 - $151,601	-5,253 Reduced 20.88%	19,910 $455,000
Q1 2021 Apr 26, 2021	SELL	$5.17 - $16.13 $165,646 - $516,805	-32,040 Reduced 56.01%	25,163 $0
Q4 2020 Feb 02, 2021	SELL	$4.01 - $7.58 $109,047 - $206,130	-27,194 Reduced 32.22%	57,203 $308,000
Q3 2020 Oct 14, 2020	BUY	$3.8 - $5.0 $320,708 - $421,985	84,397 New	84,397 $384,000
Q2 2020 Jul 13, 2020	SELL	$2.62 - $5.2 $54,503 - $108,175	-20,803 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$2.38 - $5.81 $140,619 - $343,278	-59,084 Reduced 73.96%	20,803 $65,000
Q4 2019 Feb 05, 2020	BUY	$2.31 - $3.14 $44,543 - $60,548	19,283 Added 31.82%	79,887 $206,000
Q3 2019 Oct 15, 2019	BUY	$2.22 - $3.9 $87,095 - $153,004	39,232 Added 183.57%	60,604 $191,000
Q2 2019 Jul 26, 2019	BUY	$2.75 - $3.7 $21,700 - $29,196	7,891 Added 58.53%	21,372 $72,000
Q1 2019 Apr 18, 2019	BUY	$1.68 - $3.42 $10,844 - $22,076	6,455 Added 91.87%	13,481 $0
Q4 2018 Jan 16, 2019	BUY	$1.25 - $2.75 $3,096 - $6,811	2,477 Added 54.45%	7,026 $10,000
Q3 2018 Oct 23, 2018	SELL	$2.23 - $3.82 $4,667 - $7,995	-2,093 Reduced 31.51%	4,549 $12,000
Q2 2018 Jul 30, 2018	SELL	$2.08 - $4.26 $2,392 - $4,899	-1,150 Reduced 14.76%	6,642 $17,000
Q1 2018 Apr 26, 2018	SELL	$2.32 - $3.44 $27,155 - $40,265	-11,705 Reduced 60.03%	7,792 $21,000
Q4 2017 Jan 10, 2018	BUY	$3.12 - $4.94 $11,852 - $18,767	3,799 Added 24.2%	19,497 $62,000
Q3 2017 Oct 25, 2017	BUY	$3.42 - $4.87 $53,687 - $76,449	15,698	15,698 $64,000

Others Institutions Holding AVXL

# of Institutions

163

Shares Held

26.6M

Call Options Held

515K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Anavex Life Sciences Corp. Transaction History